A CV-TMLE global test approach to improve power in rare disease clinical studies with multiple-component endpoints
利用 CV-TMLE 全局检验提高罕见病多组分终点研究的功效
Rare disease trials face unique statistical challenges due to limited patient populations and heterogeneous clinical manifestations among patients. Multiple endpoints are often necessary to comprehensively capture treatment benefits. A global test is an approach for evaluating whether a treatment has any beneficial effect across multiple endpoints. We propose a new global test based on a weighted composite endpoint. The proposed global test employs shrinkage-based…